New shot could offer safer start to opioid addiction treatment
NCT ID NCT06441604
Summary
This study is testing a new, low-dose method to help people with opioid addiction start a medication called buprenorphine. Researchers want to see if giving it as a single, long-acting injection is safe and prevents severe withdrawal symptoms. They are enrolling 30 adults who are actively using fentanyl to carefully monitor them in a hospital setting for three days.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brigham and Women's Hospital
RECRUITINGBoston, Massachusetts, 02118-5605, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.